---
document_datetime: 2023-09-21 21:20:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vydura-epar-all-authorised-presentations_en.pdf
document_name: vydura-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8364899
conversion_datetime: 2025-12-22 16:33:50.191923
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                        |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------------------------|
| EU/1/22/1645/001 | Vydura            | 75 mg      | Oral lyophilisate     | Oral use                  | blister (PVC/OPA/alu) | 2 x 1 lyophilisates (unit dose)  |
| EU/1/22/1645/002 | Vydura            | 75 mg      | Oral lyophilisate     | Oral use                  | blister (PVC/OPA/alu) | 8 x 1 lyophilisates (unit dose)  |
| EU/1/22/1645/003 | Vydura            | 75 mg      | Oral lyophilisate     | Oral use                  | blister (PVC/OPA/alu) | 16 x 1 lyophilisates (unit dose) |